ConvaTec Aktie

2,74EUR 0,00EUR 0,00%
ConvaTec für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2AUD3 / ISIN: GB00BD3VFW73

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 10 142 10 036 10 136 10 489 10 910
Umsatz pro Mitarbeiter in Mio. EUR 0,15 0,17 0,17 0,17 0,17

Bilanz (in Mio. GBP) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 820 739 682 633 699
Summe Anlagevermögen 1 892 2 247 2 231 2 173 2 112
Summe Aktiva 2 713 2 986 2 913 2 807 2 811

Bilanz (in Mio. GBP) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 1 461 1 648 1 585 1 458 1 682
Summe Eigenkapital 1 251 1 338 1 328 1 349 1 129
Summe Passiva 2 713 2 986 2 913 2 807 2 811

Adresse

Convatec, Eastborne Terrace, W2 6LG Paddington
Telefon +44 (11) 89528100
Internet http://www.convatec.com

Management

Anne Belcher
President & COO-Global Emerging Markets
Brian Michael May
Independent Non-Executive Director
Constantin Coussios
Independent Non-Executive Director
David Phillips
Treasury & Head-Investor Relations
Divakar Ramakrishnan
CTO, Head-Research & Development & EVP
Emma Rose
Chief People Officer & Executive Vice President
Evelyn Douglas
EVP, Chief Strategy & Business Development officer
Fiona Victoria Ryder
Chief Financial Officer & Financial Controller
Heather L. Mason
Independent Non-Executive Director
James Edward Spencer Kerton
Secretary, General Counsel & Executive VP
John David Gibson McAdam
Chairman
John Haller
Executive VP, Chief Quality & Operations Officer
Jonathan Peter Mason
Chief Executive Officer & Director
Kimberly S. Lody
Independent Non-Executive Director
Kjersti Grimsrud
President & Chief Operating Officer-Infusion Care
Margaret Ewing
Senior Independent Non-Executive Director
Sharon L. O'Keefe
Independent Non-Executive Director